- Report
- July 2023
Global
From €4361EUR$4,500USD£3,735GBP
- Report
- April 2021
- 795 Pages
Global
From €4361EUR$4,500USD£3,735GBP
- Report
- July 2020
- 835 Pages
Global
From €7268EUR$7,500USD£6,225GBP
- Report
- July 2020
- 795 Pages
United States
From €4361EUR$4,500USD£3,735GBP
- Report
- February 2020
- 795 Pages
Global
From €4361EUR$4,500USD£3,735GBP
- Report
- July 2019
- 835 Pages
Global
From €8238EUR$8,500USD£7,055GBP
- Report
- July 2019
- 795 Pages
United States
From €5330EUR$5,500USD£4,565GBP
- Report
- May 2019
- 795 Pages
United States
From €5330EUR$5,500USD£4,565GBP
- Report
- July 2023
- 132 Pages
Global
From €921EUR$950USD£789GBP
- Book
- July 2023
- 304 Pages
Point-of-Care (POC) Infectious Disease Tests are diagnostic tests used to detect the presence of infectious agents in a patient's sample. These tests are typically used in clinical settings, such as hospitals, clinics, and doctor's offices, and are designed to provide rapid results. POC tests are often used to diagnose acute infections, such as influenza, and can be used to monitor the progression of chronic infections, such as HIV. POC tests are also used to detect the presence of antibiotic-resistant bacteria, which can help guide treatment decisions.
POC tests are typically small, portable devices that can be used in a variety of settings, including at home. They are often designed to be user-friendly, with minimal training required for operation. Additionally, POC tests are often designed to be cost-effective, allowing for widespread use in resource-limited settings.
Some companies in the POC Infectious Disease Test market include Abbott, Becton Dickinson, Cepheid, Roche, and Siemens Healthineers. Show Less Read more